These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 28173181)

  • 1. The FMR1 promoter is selectively hydroxymethylated in primary neurons of fragile X syndrome patients.
    Esanov R; Andrade NS; Bennison S; Wahlestedt C; Zeier Z
    Hum Mol Genet; 2016 Nov; 25(22):4870-4880. PubMed ID: 28173181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reciprocal changes in DNA methylation and hydroxymethylation and a broad repressive epigenetic switch characterize FMR1 transcriptional silencing in fragile X syndrome.
    Brasa S; Mueller A; Jacquemont S; Hahne F; Rozenberg I; Peters T; He Y; McCormack C; Gasparini F; Chibout SD; Grenet O; Moggs J; Gomez-Mancilla B; Terranova R
    Clin Epigenetics; 2016; 8():15. PubMed ID: 26855684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CGG-repeat dynamics and
    Zhou Y; Kumari D; Sciascia N; Usdin K
    Mol Autism; 2016; 7():42. PubMed ID: 27713816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome.
    Sheridan SD; Theriault KM; Reis SA; Zhou F; Madison JM; Daheron L; Loring JF; Haggarty SJ
    PLoS One; 2011; 6(10):e26203. PubMed ID: 22022567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CGG Repeat-Induced FMR1 Silencing Depends on the Expansion Size in Human iPSCs and Neurons Carrying Unmethylated Full Mutations.
    Brykczynska U; Pecho-Vrieseling E; Thiemeyer A; Klein J; Fruh I; Doll T; Manneville C; Fuchs S; Iazeolla M; Beibel M; Roma G; Naumann U; Kelley N; Oakeley EJ; Mueller M; Gomez-Mancilla B; Bühler M; Tabolacci E; Chiurazzi P; Neri G; Bouwmeester T; Di Giorgio FP; Fodor BD
    Stem Cell Reports; 2016 Dec; 7(6):1059-1071. PubMed ID: 27840045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylases suppress CGG repeat-induced neurodegeneration via transcriptional silencing in models of fragile X tremor ataxia syndrome.
    Todd PK; Oh SY; Krans A; Pandey UB; Di Prospero NA; Min KT; Taylor JP; Paulson HL
    PLoS Genet; 2010 Dec; 6(12):e1001240. PubMed ID: 21170301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rescue of Fragile X Syndrome Neurons by DNA Methylation Editing of the FMR1 Gene.
    Liu XS; Wu H; Krzisch M; Wu X; Graef J; Muffat J; Hnisz D; Li CH; Yuan B; Xu C; Li Y; Vershkov D; Cacace A; Young RA; Jaenisch R
    Cell; 2018 Feb; 172(5):979-992.e6. PubMed ID: 29456084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fragile X syndrome full mutation in cognitively normal male identified as part of an Australian reproductive carrier screening program.
    Jarmolowicz AI; Baker EK; Bartlett E; Francis D; Ling L; Gamage D; Delatycki MB; Godler DE
    Am J Med Genet A; 2021 May; 185(5):1498-1503. PubMed ID: 33544979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversion of FMR1 Methylation and Silencing by Editing the Triplet Repeats in Fragile X iPSC-Derived Neurons.
    Park CY; Halevy T; Lee DR; Sung JJ; Lee JS; Yanuka O; Benvenisty N; Kim DW
    Cell Rep; 2015 Oct; 13(2):234-41. PubMed ID: 26440889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FMR1 CGG repeat lengths mediate different regulation of reporter gene expression in comparative transient and locus specific integration assays.
    Sølvsten C; Nielsen AL
    Gene; 2011 Oct; 486(1-2):15-22. PubMed ID: 21767618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of the transcriptional landscape of the human FMR1 gene reveals two new long noncoding RNAs differentially expressed in Fragile X syndrome and Fragile X-associated tremor/ataxia syndrome.
    Pastori C; Peschansky VJ; Barbouth D; Mehta A; Silva JP; Wahlestedt C
    Hum Genet; 2014 Jan; 133(1):59-67. PubMed ID: 24005575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylated premutation of the FMR1 gene in three sisters: correlating CGG expansion and epigenetic inactivation.
    Tabolacci E; Pomponi MG; Remondini L; Pietrobono R; Nobile V; Pennacchio G; Gurrieri F; Neri G; Genuardi M; Chiurazzi P
    Eur J Hum Genet; 2020 May; 28(5):567-575. PubMed ID: 31804632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA Methylation, Mechanisms of
    Nobile V; Pucci C; Chiurazzi P; Neri G; Tabolacci E
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33669384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetics of fragile X syndrome and fragile X-related disorders.
    Kraan CM; Godler DE; Amor DJ
    Dev Med Child Neurol; 2019 Feb; 61(2):121-127. PubMed ID: 30084485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CNS expression of murine fragile X protein (FMRP) as a function of CGG-repeat size.
    Ludwig AL; Espinal GM; Pretto DI; Jamal AL; Arque G; Tassone F; Berman RF; Hagerman PJ
    Hum Mol Genet; 2014 Jun; 23(12):3228-38. PubMed ID: 24463622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of FXS-A9 panel with a single human X chromosome from fragile X syndrome-associated individual.
    Nakayama Y; Adachi K; Shioda N; Maeta S; Nanba E; Kugoh H
    Exp Cell Res; 2021 Jan; 398(2):112419. PubMed ID: 33296661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [FMR1 PREMUTATION CARRIERS - ARE THEY REALLY ASYMPTOMATIC?].
    Elizur S; Berkenstadt M; Ries-Levavi L; Gruber N; Pinhas-Hamiel O; Hassin-Baer S; Raas-Rothschild A; Raanani H; Cukierman-Yaffe T; Orvieto R; Cohen Y; Gabis L
    Harefuah; 2018 Apr; 157(4):241-244. PubMed ID: 29688643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fragile X syndrome and FMR1-dependent diseases - clinical presentation, epidemiology and molecular background].
    Landowska A; Rzońca S; Bal J; Gos M
    Dev Period Med; 2018; 22(1):14-21. PubMed ID: 29641417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056.
    Jacquemont S; Curie A; des Portes V; Torrioli MG; Berry-Kravis E; Hagerman RJ; Ramos FJ; Cornish K; He Y; Paulding C; Neri G; Chen F; Hadjikhani N; Martinet D; Meyer J; Beckmann JS; Delange K; Brun A; Bussy G; Gasparini F; Hilse T; Floesser A; Branson J; Bilbe G; Johns D; Gomez-Mancilla B
    Sci Transl Med; 2011 Jan; 3(64):64ra1. PubMed ID: 21209411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chromatin changes caused by CGG repeat expansion in fmr1 gene].
    Yudkin DV; Lemskaya NA; Grischenko IV; Dolskiy AA
    Mol Biol (Mosk); 2015; 49(2):205-11. PubMed ID: 26065250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.